Advancing discovery through Alluvi research

Alluvi Labs develops and evaluates premium peptides and supplements. All products are produced exclusively for controlled research and development purposes, guided by science.

Alluvi Pens
Alluvi Retatrutide 40mg

Part of Alluvi Labs’ ongoing research program into advanced GLP-1 multi-agonist compounds. This formulation is supplied in controlled batches for laboratory analysis of stability, compound behaviour, and injector system performance.

Popular courses​

Clinical Study based on 600 calorie reduction in daily intake

Participants consumed fewer calories per day without being instructed to diet – driven by decreased appetite and satiety signaling. Provided strictly as scientific context.

22.5% loss in weight using Retatrutide

Reference value drawn from published research on GLP-1 multi-agonist compounds. Provided strictly as scientific context.

18.3 KG

Average weight loss during clinical trial period of 48 weeks on high-dose Retatrutide. Example data point referenced in peer-reviewed studies for GLP-1 multi-agonists.

What my students say about the courses​

Ready to commence your weight-loss journey?​

Stay in the know

Subscribe mailing list

Newsletter
Follow Us

Free, Secure & Worldwide Shipping

X
Scroll to Top